SYNBAL INC

CARLSBAD, CA · Biotech · Defunct

Humanized rat models with knocked-out rat drug metabolism genes and knocked-in human counterparts, engineered using Active Gene Drive technology for accelerated genetic modification

synbal.com →
Grants
$4.1M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Triple humanized ACE2-TMPRSS-FcGRT mouse models for COVID research in the C57BU6 and BALBIc backgrounds.$233,363
Federal grantDepartment of Health and Human Services · Phase II · Triple humanized ACE2-TMPRSS-FcGRT mouse models for COVID research in the C57BU6 and BALBIc backgrounds.$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Triple humanized ACE2-TMPRSS-FcGRT mouse models for COVID research in the C57BU6 and BALBIc backgrounds.$566,896
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3148ExQor Technologies Inc——
3149Lung Biotechnology——
3150VIBE PHARMACEUTICALS LLC——
3151SYNBAL INC——
3152ANANEO THERAPEUTICS INC——
3153BLOOD CELL TECHNOLOGIES LLC——
3154PETAOMICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Humanized Mouse Models For Study Of COVID-19application
  • Humanized Mouse Models For Study Of COVID-19application

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.